Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited)

v3.5.0.2
CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) - Balance Sheets - USD ($)
Sep. 30, 2016
Dec. 31, 2015
Current Assets:    
Cash $ 774,363 $ 3,165
Escrow fund 214,750
Deferred contract software development costs - related party 55,938
Prepaid expenses and other current assets 10,971 3,000
Total current assets 1,000,084 62,103
Other Assets:    
Goodwill 6,160,229
Property and equipment, net 41,887 42,297
Deposit 44,876
Total Assets 7,247,076 104,400
Current Liabilities:    
Accounts payable and accrued expenses 35,829 2,617
Notes payable - related party 174,058
Unearned revenue - related party 156,000
Loans from officer 161,800
Total current liabilities 209,887 320,417
Long Term Liabilities:    
Convertible notes payable 25,000
Accrued interest 1,593
Derivative liability 1,103,276
Total long term liabilities 1,103,276 26,593
Total liabilities 1,313,163 347,010
Commitments and Contingencies
Mezzanine Equity    
Preferred Series A stock, par value $.01 per share, 134,000 shares authorized; 133,334 and 0 shares issued and outstanding at September 30, 2016 and December 31, 2015, respectively . Stated at redemption value net of discount. 396,728
Shareholders' Equity/(Deficit):    
Preferred Stock, par value $.01, 10,000,000 shares authorized all series [1] 212
Common stock, par value $.001 per share, 500,000,000 shares authorized; 430,087,964 and 414,000,000 shares issued and outstanding at September 30, 2016 and December 31, 2015, respectively 430,088 414,000
Additional paid-in capital 6,372,596 (164,000)
Accumulated deficit (1,265,711) (492,610)
Total shareholders' equity/(deficit) 5,537,185 (242,610)
Total Liabilities and Shareholders' Equity/(Deficit) $ 7,247,076 $ 104,400
[1] Preferred Series A-1 stock, par value $.01 per share, 21,000 shares authorized; 20,371 and 0 shares issued and outstanding at September 30, 2016 and December 31, 2015, respectively; Preferred Series B stock, par value $.01 per share, 300,000 shares authorized; no shares issued and outstanding at September 30, 2016 and December 31, 2015, respectively; Series C stock, par value $.01 per share, 753 and 0 shares issued and outstanding at September 30, 2016 and December 31, 2015, respectively